Dear editor:

We read with great interest the article by Dr. Woodward and colleagues \[[@CR1]\], "Toll-like receptor 4 in glial inflammatory responses to air pollution in vitro and in vivo" which appeared in the 15 April 2017 of Journal of Neuroinflammation. Since the results of the article is very attractive for us, we collected original data from NCBI (<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391610/bin/12974_2017_858_MOESM1_ESM.zip>) which has been submitted by Woodward et al. and used different methods to perform the bioinformatics analysis in each group; however, we get different results against the article, and we think the author's methods in bioinformatics analysis are inappropriate (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1The difference of normalization between RMA and gcRMA

We noticed that the author used significance analysis microarrays (SAM) in differentially expressed gene (DEG) analysis which, usually, cause high false positives. We utilize a fewer false positives method, Limma (Linear Models for Microarray Analysis) \[[@CR2]\] package, which was widely used statistical tests to obtain differential expression based on R programming language and more accurate than SAM. The results showed 572 RNAs (contain 22 LncRNAs) were differentially expressed between the "control cultures" and "nPM-treated" groups (FDR \< 0.05, \|logFC\| \> 1), and 1931 RNAs (contain 147 LncRNAs) were differentially expressed between the "control cultures" and "LPS-treated" groups (FDR \< 0.05, \|logFC\| \> 1) (Additional files [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"}). Due to the high false positives, the number of DEGs which were detected by SAM are more than our results. So for high-level analysis, we suggest using Limma or combining more than one method and then only taking the common genes of all methods to get more accurate results \[[@CR3]\].

Moreover, for preprocessing microarray data, we recommend using GeneChip Robust Multi-array Averaging (gcRMA). We found that the author used RMA method which results of normalization are very close to gcRMA \[[@CR4]\], but gcRMA is an improved algorithm of RMA that can be used to achieve a more accurate expression of the gene chip probes by using sequence-specific probes (Fig. [1](#Fig1){ref-type="fig"}). Attached figure shows that the gcRMA is better than RMA in raw data normalization.

Additional files
================

 {#Sec2}

Additional file 1:Differentially expressed RNAs between "LPS-treated"and control groups. (CSV 50 kb) Additional file 2:Differentially expressed RNAs between "nPM-treated"and control groups. (CSV 167 kb)

DEG

:   Differentially expressed genes

FDR

:   False discovery rate

gcRMA

:   GeneChip Robust Multi-array Averaging

Limma

:   Linear models for microarray analysis

LncRNA

:   Long non-coding RNA

LPS

:   Lipopolysaccharide

NCBI

:   National Center for Biotechnology Information

nPM

:   Nanoscale particulate matter

RMA

:   Robust Multi-array Averaging

SAM

:   Significance analysis microarrays
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Dear Dr. Li,

While we recognize the issues surrounding false discoveries, we do not agree with your comment suggesting "that the methods in bioinformatics analysis \[employed in our study\] are inappropriate". We are not surprised that your Limma bioinformatics findings differed slightly from SAM in relation to the number of responding genes, which of course varies by method and criteria, because of this reasoning that we tested the robustness of our results using a variety of distinct approaches, rather than relying on any one in particular. Further, our conclusions pointing to the importance of the TLR4 pathway are not based on the number of differentially expressed genes---which you imply may be biased---but rather are substantiated by findings derived from state-of-the-art systems biology approaches. For instance, the set of differentially expressed genes based on SAM (which we acknowledge may include false positives) was further analyzed using pathway enrichment and gene ontology analysis. Similarly, our findings were further substantiated using WGCNA---a network analysis approach that identifies higher order modules, rather than individual genes, and thus has been shown to be more robust when it comes to gaining biological insight from high-dimensional data. Finally, and perhaps most importantly, we successfully validated our findings with further experiments both in vitro and in vivo.
